Immunomodulation as a Protective Strategy in Chronic Otitis Media

Medicine and Dentistry

• Middle Ear 100%
• Epithelial Cell 50%
• Hyperplasia 50%
• Otitis Media 50%
• Middle Ear Mucosa 50%
• Serositis 33%
• Tumor Necrosis Factor 33%
• Programmed Cell Death 33%
• Protein Expression 33%
• Immunity 16%
• In Vitro 16%
• Human Tissue 16%
• Cell Signaling Pathway 16%
• Real-Time Polymerase Chain Reaction 16%
• Signaling Molecule 16%
• External Auditory Canal 16%
• Immune System Receptors 16%
• Leukocyte 16%
• Transcription Factor 16%
• Bacterial Clearance 16%